Treatment options in extravasation injury: An experimental study in rats

Plastic and Reconstructive Surgery

Volumn 109, Issue 7, 2002, Pages 2418-2423

  Yilmaz, Mustafa ^a   Demirdover, Cenk ^a   Mola, Fahri ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; ANTINEOPLASTIC AGENT; ASCORBIC ACID; CIMETIDINE; DIMETHYL SULFOXIDE; DIPHENHYDRAMINE; DOXORUBICIN; HEPARIN; HYALURONIDASE; LIDOCAINE;

ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DNA BINDING; EXPERIMENTAL MODEL; EXTRAVASATION; HISTOPATHOLOGY; HYPERBARIC OXYGEN; INJECTION SITE; NONHUMAN; PRIORITY JOURNAL; RAT; SKIN NECROSIS; SUCTION; TISSUE NECROSIS;

EID: 0036105708     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006534-200206000-00036     Document Type: Article

References (17)

1. Prevention of Adriamycin-induced full-thickness skin loss using hyaluronidase infiltration
2. Managing skin damage induced by doxorubicin hydrochloride and daunorubicin hydrochloride
3. Cold protection and heat enhancement of doxorubicin skin toxicity in the mouse
4. Prevention of Adriamycin-induced skin necrosis with various free radical scavengers
5. Protective effect of doxorubicin in vitamin C or dimethyl sulfoxide against skin ulceration in pig
6. Pharmacological antidotes to experimental doxorubicin skin toxicity: A suggested role for beta-adrenergic compounds
7. Hyperbaric oxygen therapy and free radical production: An experimental study in doxorubicin (Adriamycin) extravasation injuries
8. Failure of DMSO and vitamin E to prevent doxorubicin skin ulceration in the mouse
9. Inhibition of oxidation of methyl linoleate in solution by vitamin E and vitamin C
10. Influence of beta carotene, vitamin E, and vitamin C on endogenous antioxidant defenses in erythrocytes
11. Early and late treatment of iatrogenic injection damage
12. Extravasation injuries and subcutaneous aspiration in children
13. Histopathological changes in Adriamycin extravasation injury
14. Extravasation injuries and emergency suction as treatment
15. Experimental skin necrosis produced by Adriamycin
16. Long persistence of doxorubicin in human skin after extravasation
17. Skin cancer occurring 10 years after the extravasation of doxorubicin